4 Small Caps Ready to Surge

NASDAQ: CCXI | ChemoCentryx, Inc. News, Ratings, and Charts

CCXI – If you know where to look, small caps offer the best opportunities. ChemoCentryx (CCXI), Itron (ITRI), Addus Homecare (ADUS) and Unisys (UIS) are interesting companies with plenty of upside.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Over the past decade, small caps have underperformed large-cap stocks. Historically, asset class performance has been mean-reverting.

 

This means that longer periods of underperformance are followed by equal amounts of outperformance. Thus, investors should examine the universe of small-cap stocks, if they are interested in finding the next big winner.

 

Small-cap stocks have more potential for growth and upside. They are often neglected simply because most investors are focused on bigger stocks. But, this is disinterest also creates an opportunity to find strong companies. With market capitalizations between a couple hundred million and a couple billion, small caps might not make the headlines yet they are certainly worthy of your attention.

 

Below, we provide a look at four intriguing small-cap stocks every investor should consider adding to his or her portfolio:

ChemoCentryx (CCXI)

Biopharma companies are somewhat of a safe haven as we move deeper into the current recession. CCXI is a biopharma small-cap making significant headway in the oral administration of small molecule therapies that treat inflammatory diseases, autoimmune disorders, and cancer. It has a number of products in clinical trials that could turn the stock into a mid-cap if they are successful. CCXI has seen a steady increase in institutional ownership and is held in size by a number of specialized biotech funds with a track record of success like RA Capital and Consonance Capital Management.

The POWR Ratings show CCXI has a Buy rating with As in each POWR Component but for a B Buy & Hold grade. CCXI is ranked in the top 40 of all 338 stocks in the Biotech category.

CCXI’s average analyst price target is $72.57, which is 24% above current prices.

Itron (ITRI)

Water is now a common topic of discussion in investing circles as the global population swells and access to potable water becomes that much more challenging.ITRI works in unison with water utilities to make the most of their water services. As an example, ITRI measures and analyzes water use to facilitate the most efficient use of this valuable commodity. The company does the same with electricity for electricity providers.

ITRI’s services will only become that much more important as the world’s population continues to boom and finite resources dwindle. ITRI’s long-term growth rate of 17.5% outpaces that of the utility sector. Its revenues are stable since it services utilities.

The POWR Ratings show ITRI has respectable Buy & Hold and Peer grades along with a top-10 industry rank out of 35 stocks in the Industrial – Services sector.

The analysts have set a price target of $77.17 for ITRI, who are mostly bullish on the stock.

Addus HomeCare (ADUS)

In-home personal care is quickly becoming quite important as the baby boomer age cohort transitions to the golden years. Most baby boomers are hesitant to consider an assisted living facility or a nursing home. This means the in-home care services provided by ADUS will prove even more important in the months and years to come. ADUS has nearly 35,000 employees who care for seniors at their homes.

ADUS has a long-term growth rate target of 15%, a figure that could move even higher as the aging population steadfastly refuses to enter assisted care living facilities in an effort to avoid contracting the virus. Staying in one’s home also helps maintain in-person contact with friends and family (while social distancing, of course).

The POWR Ratings show ADUS has B grades in each POWR Component but for its Trade grade of C. The average analyst price target for ADUS is $104, indicating it has nearly 20% upside. All in all, five analysts recommend buying ADUS while none recommend holding or selling.

Unisys Corp (UIS)

It is not often you find a reasonably priced small-cap tech stock like UIS. UIS provides information technology consulting services including outsourcing, digital security, network solutions and data analytics.

UIS has not yet returned to its pre-COVID trading level of $16 to $18. The stock bounced back to the $10 to $12 level after temporarily dipping down to $8 and change in mid-March. UIS is an interesting turn-around opportunity. It has a forward price to earnings of 5, indicating a very reasonable valuation.

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

Top 5 WINNING Stock Chart Patterns

7 “Safe-Haven” Dividend Stocks for Turbulent Times


CCXI shares were trading at $59.35 per share on Wednesday morning, up $0.75 (+1.28%). Year-to-date, CCXI has gained 50.06%, versus a 1.38% rise in the benchmark S&P 500 index during the same period.


About the Author: Patrick Ryan


Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CCXIGet RatingGet RatingGet Rating
ADUSGet RatingGet RatingGet Rating
UISGet RatingGet RatingGet Rating
ITRIGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Why is the Stock Market Tanking Now?

Stocks (SPY) are tumbling lower the past week. Some point to the spike in the Coronavirus as the main cause. Others talk about the lack of a stimulus deal behind this move. But perhaps it is something else entirely. Get the full story here…

:  |  News, Ratings, and Charts

2021 Stock Market Outlook: Upside & Pitfalls

Get Steve Reitmeister’s game plan to outperform the market (SPY) in year to come. He will also share his unique “Formula for 2021 Success” which includes examples of how this indicator led to big gains in ETSY and NVDA in 2020. Read on for more...

:  |  News, Ratings, and Charts

Forget Tesla, Buy These 3 Stocks to Profit from the Electric Vehicle Revolution

As Tesla (TSLA), and now NIO (NIO), get all the headlines in the EV industry, they may not be the best stocks to buy right now due to sky high valuations. Another way to profit from this red hot industry is through stocks of companies that make parts used in the manufacturing of EVs. Here are three great stocks that should see strong growth as the industry grows: Aptiv PLC (APTV), Cree, Inc (CREE), and Analog Devices (ADI).

:  |  News, Ratings, and Charts

3 Stocks That Could Make New Highs in November

The market is poised to be highly volatile in the coming weeks due to rising COVID-19 infections as we near the presidential election. So it might be a good idea to consider stocks based on strong financials and recent analyst upgrades. Workday, Inc. (WDAY), Whirlpool Corporation (WHR), and PulteGroup, Inc. (PHM) are three such stocks that could hit new highs in the near future.

:  |  News, Ratings, and Charts

Forget Tesla, Buy These 3 Stocks to Profit from the Electric Vehicle Revolution

As Tesla (TSLA), and now NIO (NIO), get all the headlines in the EV industry, they may not be the best stocks to buy right now due to sky high valuations. Another way to profit from this red hot industry is through stocks of companies that make parts used in the manufacturing of EVs. Here are three great stocks that should see strong growth as the industry grows: Aptiv PLC (APTV), Cree, Inc (CREE), and Analog Devices (ADI).

Read More Stories

More ChemoCentryx, Inc. (CCXI) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CCXI News